Hanoun, Maher
Ruhnke, Leo
Kramer, Michael
Hanoun, Christine
Schäfer-Eckart, Kerstin
Steffen, Björn
Sauer, Tim
Krause, Stefan W.
Schliemann, Christoph
Mikesch, Jan-Henrik
Kaufmann, Martin
Hänel, Mathias
Jost, Edgar
Brümmendorf, Tim H.
Fransecky, Lars
Kraus, Sabrina
Einsele, Hermann
Niemann, Dirk
Neubauer, Andreas
Kullmer, Johannes
Seggewiss-Bernhard, Ruth
Görner, Martin
Held, Gerhard
Kaiser, Ulrich
Scholl, Sebastian
Hochhaus, Andreas
Reinhardt, H. Christian
Platzbecker, Uwe
Baldus, Claudia D.
Müller-Tidow, Carsten
Bornhäuser, Martin
Serve, Hubert
Röllig, Christoph
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry
https://doi.org/10.1007/s00432-022-04356-9
Funding for this research was provided by:
Universitätsklinikum Essen
Article History
Received: 14 August 2022
Accepted: 9 September 2022
First Online: 28 September 2022
Declarations
:
: AH: research support by Novartis, BMS, Pfizer, Incyte.
: The study protocol has been approved by the ethics committees of all participating centers and the study is registered (NCT03188874).